Concordance of plasmatic circulating DNA and matched metastatic tissue in metastatic urothelial carcinoma

Autor: I. Duquesne, N. Menssouri, N. Pata-Merci, R. Tang, M. Ngo-Camus, C. Nicotra, J.Y. Scoazec, C. Massard, B. Besse, E. Rouleau, Y. Loriot

Publikováno v: European Urology Open Science, Vol 19, Iss , Pp e200- (2020)

Externí odkaz: https://doaj.org/article/56750636e6cc4cdcb52ead2139b59e33

Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)

Autor: A, Bayle, F, Peyraud, L, Belcaid, M, Brunet, M, Aldea, R, Clodion, P, Dubos, D, Vasseur, C, Nicotra, A, Geraud, M, Sakkal, L, Cerbone, F, Blanc-Durand, F, Mosele, P, Martin Romano, M, Ngo Camus, I, Soubeyran, E, Khalifa, M, Alame, L, Blouin, D, Dinart, C, Bellera, A, Hollebecque, S, Ponce, Y, Loriot, B, Besse, L, Lacroix, E, Rouleau, F, Barlesi, F, Andre, A, Italiano

Publikováno v: Annals of Oncology. 33:1328-1331

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db0742a836d243bf71b6189c3d9ca500
https://doi.org/10.1016/j.annonc.2022.08.089

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer:phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis

Autor: S I, Labidi-Galy, M, Rodrigues, J L, Sandoval, J E, Kurtz, F, Heitz, A M, Mosconi, I, Romero, U, Denison, S, Nagao, I, Vergote, G, Parma, T J, Nøttrup, E, Rouleau, G, Garnier, A, El-Balat, C, Zamagni, C, Martín-Lorente, E, Pujade-Lauraine, A, Fiévet, I L, Ray-Coquard

Publikováno v: Labidi-Galy, S I, Rodrigues, M, Sandoval, J L, Kurtz, J E, Heitz, F, Mosconi, A M, Romero, I, Denison, U, Nagao, S, Vergote, I, Parma, G, Nøttrup, T J, Rouleau, E, Garnier, G, El-Balat, A, Zamagni, C, Martín-Lorente, C, Pujade-Lauraine, E, Fiévet, A & Ray-Coquard, I L 2023, ' Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer : phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis ', Annals of Oncology, vol. 34, no. 2, pp. 152-162 . https://doi.org/10.1016/j.annonc.2022.11.003

BACKGROUND: In the phase III PAOLA-1 study, the addition of maintenance olaparib to bevacizumab in patients with newly diagnosed high-grade ovarian cancer (HGOC) resulted in prolonged progression-free survival (PFS), particularly for homologous recom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7238bd7941a935684f35290251f1a332
https://curis.ku.dk/ws/files/338357926/1_s2.0_S0923753422047330_main.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.